Pricing Log in Create free account

Aprea Therapeutics, Inc. (APRE) vs Soligenix Inc. (SNGX)

Aprea Therapeutics, Inc. and Soligenix Inc. are both Biotechnology companies. Aprea Therapeutics, Inc. and Soligenix Inc. are of similar size ($7.8M and $7.7M). Soligenix Inc. grew revenue faster over the last twelve months: −50.4% against −81.0%. Across the 13 metrics below, Aprea Therapeutics, Inc. leads on 8 and Soligenix Inc. on 5.

Valuation

Metric APRE SNGX Biotechnology median
P/E n/m n/m 8.50
P/S 108.58 11.29 9.71
P/B 0.81 0.84 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.77 0.17 0.64
EV/Sales (35.75) (3.73) 9.21
Earnings yield (186.21%) (211.20%) (33.15%)
Free cash flow yield (39.30%) (174.60%) (25.50%)

Profitability

Metric APRE SNGX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.44%) (241.65%) (56.36%)
Return on assets (41.30%) (125.95%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APRE SNGX Biotechnology median
Revenue growth (TTM) (80.99%) (50.37%) 6.02%
EPS growth (last fiscal year) 17.87% 57.03% 30.26%
Revenue growth, 5-year CAGR — (51.88%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APRE SNGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.55 2.77 4.72
Net debt to EBITDA 1.11 0.67 0.96

Dividend

Metric APRE SNGX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric APRE SNGX Biotechnology median
Market cap 7.78m 7.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack